11/24
08:00 am
qncx
Quince Therapeutics to Participate at Investor Events in December 2025
High
Report
Quince Therapeutics to Participate at Investor Events in December 2025
11/13
09:01 am
qncx
Quince Therapeutics (NASDAQ:QNCX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $4.00 price target on the stock.
Low
Report
Quince Therapeutics (NASDAQ:QNCX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $4.00 price target on the stock.
11/12
04:05 pm
qncx
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
Low
Report
Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
11/10
04:05 pm
qncx
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
Low
Report
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
10/9
04:25 pm
qncx
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting [Yahoo! Finance]
Medium
Report
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting [Yahoo! Finance]
10/9
04:05 pm
qncx
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
Medium
Report
Quince Therapeutics Presents Data from Patient-Reported Walking Capacity in Children with Ataxia-Telangiectasia at 54th Child Neurology Society Annual Meeting
10/2
05:33 pm
qncx
Aqua Metals files to sell 1M shares of common stock for holders [Seeking Alpha]
Low
Report
Aqua Metals files to sell 1M shares of common stock for holders [Seeking Alpha]
10/2
05:13 pm
qncx
Quince Therapeutics, Inc. (QNCX) Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
Quince Therapeutics, Inc. (QNCX) Analyst/Investor Day Transcript [Seeking Alpha]
9/26
08:05 am
qncx
Quince Therapeutics (NASDAQ:QNCX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $4.00 price target on the stock.
Medium
Report
Quince Therapeutics (NASDAQ:QNCX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $4.00 price target on the stock.
9/25
04:30 pm
qncx
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study [Yahoo! Finance]
Medium
Report
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study [Yahoo! Finance]
9/25
04:05 pm
qncx
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study
Low
Report
Quince Therapeutics Announces CPT: Pharmacometrics & Systems Pharmacology Publication of eDSP Population Pharmacokinetic Modeling Study
9/24
01:16 am
qncx
Quince Therapeutics, Inc. - Special Call [Seeking Alpha]
Medium
Report
Quince Therapeutics, Inc. - Special Call [Seeking Alpha]
9/11
04:05 pm
qncx
Quince Therapeutics to Host Virtual Investor Day on October 2, 2025
Low
Report
Quince Therapeutics to Host Virtual Investor Day on October 2, 2025